CSL Archives - InnovationAus

Policy Science Skills

Academy calls for manufacturing boost for vaccines

Without the ability to produce vaccines onshore, Australia and the region remain vulnerable to supply shocks and ‘vaccine nationalism’, the Academy of Science says in a pre-budget submission to...

Vaccine maker CSL’s massive year, massive profits

18 February 2021 | by Peter Roberts

Australia’s largest company by market capitalisation, biotechnology manufacturer CSL has powered ahead in the first half of the financial year reporting a net profit after tax up 44 per...

The Pivot: Lessons from the biotech frontline

18 November 2020 | by Ian Nisbet

“If plan A doesn’t work, the alphabet has 25 more letters – 46 if you’re in Japan.” (Claire Cook, Seven Year Switch) In the late 1980s and early 1990s...

CSL to build $800m Melbourne vaccine facility

16 November 2020 | by Peter Roberts

Biotechnology giant CSL will spend more than $800 million building a new vaccine manufacturing plant at the Melbourne Airport Business Park, with operations expected to start in 2026. The...

Govt seeks input on mass vaccine capability

12 August 2020 | by James Riley

The federal government has put out a nationwide call to local manufacturers seeking information as part of preparation to produce future vaccines and treatments for COVID-19 at scale. The...